Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Quick facts

Marketed products

• Bridge therapy · Neurology
  Bridge therapy refers to a transitional treatment strategy that maintains disease control while switching between long-term therapies.
• Prophylactic · Other
• Symptomatic drugs · Neurology
  Symptomatic drugs provide relief from disease symptoms without targeting the underlying pathological mechanism.

Phase 2 pipeline

• ZK 219477

Phase 1 pipeline

• GSC-loaded autologous dendritic cells
• Pharmacological prophylaxis

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta portfolio CI brief
• Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta pipeline updates RSS

Frequently asked questions about Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Related

• Bridge therapy · Neurology
• Prophylactic · Other
• Symptomatic drugs · Neurology
• Sector hub: All tracked pharma companies